Efficacy and safety of isavuconazole versus voriconazole for the treatment of invasive aspergillosis: a systematic review and meta-analysis

Authors

Publication Details

Journal
BMC Infectious Diseases
Published
2026-10-24
DOI
https://doi.org/10.1186/s12879-026-14686-5
Primary Topic
Antifungal resistance and susceptibility
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of isavuconazole versus voriconazole for the treatment of invasive aspergillosis: a systematic review and meta-analysis

Xunyan Zhang, Lin Yuan, Pingxiu Tang, Qiang Yang
BMC Infectious Diseases
Antifungal resistance and susceptibility
article

Efficacy and safety of isavuconazole versus voriconazole for the treatment of invasive aspergillosis: a systematic review and meta-analysis

Xunyan Zhang, Lin Yuan, Pingxiu Tang, Qiang Yang
article en

Abstract

No abstract available for this paper.
BMC Infectious Diseases
Openalex Percentile: Top 12%
Antifungal resistance and susceptibility
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Efficacy and safety of isavuconazole versus voriconazole for the treatment of invasive aspergillosis: a systematic review and meta-analysis — Xunyan Zhang, Lin Yuan, et al. · BMC Infectious Diseases (2026) | TGRS Research Map | TGRS